Google is seeking input from pharmaceutical marketers and the FDA on two potential ad formats that would allow marketers to include a brand name in paid search ads by adding an additional line of text to post drug risks and including a link to so-called "fair balance" information. Such ads listing product names and side effects yield fewer clicks than ads without such information, but produce better leads for Google and the marketers and higher-quality search for users.

Related Summaries